{"id":"https://openalex.org/W4287093360","doi":"https://doi.org/10.3389/fimmu.2022.925821","title":"Antibodies targeting Candida albicans Als3 and Hyr1 antigens protect neonatal mice from candidiasis","display_name":"Antibodies targeting Candida albicans Als3 and Hyr1 antigens protect neonatal mice from candidiasis","publication_year":2022,"publication_date":"2022-07-22","ids":{"openalex":"https://openalex.org/W4287093360","doi":"https://doi.org/10.3389/fimmu.2022.925821","pmid":"https://pubmed.ncbi.nlm.nih.gov/35935947","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9355692"},"language":"en","primary_location":{"id":"doi:10.3389/fimmu.2022.925821","doi":"https://doi.org/10.3389/fimmu.2022.925821","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2022.925821","pdf_url":null,"source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.3389/fimmu.2022.925821","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013000959","display_name":"Shakti Singh","orcid":"https://orcid.org/0000-0001-6521-0998","observed_orcids":["https://orcid.org/0000-0001-6521-0998"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I177607063","display_name":"The Lundquist Institute","ror":"https://ror.org/025j2nd68","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I177607063"]},{"id":"https://openalex.org/I2801403999","display_name":"UCLA Medical Center","ror":"https://ror.org/04vq5kb54","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801403999"]},{"id":"https://openalex.org/I4210165985","display_name":"Harbor\u2013UCLA Medical Center","ror":"https://ror.org/05h4zj272","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1328359107","https://openalex.org/I4210165985"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shakti Singh","raw_affiliation_strings":["Division of Infectious Diseases, The Lundquist Institute for Biomedical Innovation at Harbor, University of California Los Angeles (UCLA) Medical Center, Torrance, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infectious Diseases, The Lundquist Institute for Biomedical Innovation at Harbor, University of California Los Angeles (UCLA) Medical Center, Torrance, CA, United States","institution_ids":["https://openalex.org/I161318765","https://openalex.org/I177607063","https://openalex.org/I2801403999","https://openalex.org/I4210165985"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090732189","display_name":"Sunna Nabeela","orcid":"https://orcid.org/0000-0002-8066-2199","observed_orcids":["https://orcid.org/0000-0002-8066-2199"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I177607063","display_name":"The Lundquist Institute","ror":"https://ror.org/025j2nd68","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I177607063"]},{"id":"https://openalex.org/I2801403999","display_name":"UCLA Medical Center","ror":"https://ror.org/04vq5kb54","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801403999"]},{"id":"https://openalex.org/I4210165985","display_name":"Harbor\u2013UCLA Medical Center","ror":"https://ror.org/05h4zj272","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1328359107","https://openalex.org/I4210165985"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sunna Nabeela","raw_affiliation_strings":["Division of Infectious Diseases, The Lundquist Institute for Biomedical Innovation at Harbor, University of California Los Angeles (UCLA) Medical Center, Torrance, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infectious Diseases, The Lundquist Institute for Biomedical Innovation at Harbor, University of California Los Angeles (UCLA) Medical Center, Torrance, CA, United States","institution_ids":["https://openalex.org/I161318765","https://openalex.org/I177607063","https://openalex.org/I2801403999","https://openalex.org/I4210165985"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045613767","display_name":"Ashley M Barbarino","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I177607063","display_name":"The Lundquist Institute","ror":"https://ror.org/025j2nd68","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I177607063"]},{"id":"https://openalex.org/I2801403999","display_name":"UCLA Medical Center","ror":"https://ror.org/04vq5kb54","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801403999"]},{"id":"https://openalex.org/I4210165985","display_name":"Harbor\u2013UCLA Medical Center","ror":"https://ror.org/05h4zj272","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1328359107","https://openalex.org/I4210165985"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ashley Barbarino","raw_affiliation_strings":["Division of Infectious Diseases, The Lundquist Institute for Biomedical Innovation at Harbor, University of California Los Angeles (UCLA) Medical Center, Torrance, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infectious Diseases, The Lundquist Institute for Biomedical Innovation at Harbor, University of California Los Angeles (UCLA) Medical Center, Torrance, CA, United States","institution_ids":["https://openalex.org/I161318765","https://openalex.org/I177607063","https://openalex.org/I2801403999","https://openalex.org/I4210165985"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032603923","display_name":"Ashraf S. Ibrahim","orcid":"https://orcid.org/0000-0003-3787-8530","observed_orcids":["https://orcid.org/0000-0003-3787-8530"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I177607063","display_name":"The Lundquist Institute","ror":"https://ror.org/025j2nd68","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I177607063"]},{"id":"https://openalex.org/I2801403999","display_name":"UCLA Medical Center","ror":"https://ror.org/04vq5kb54","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801403999"]},{"id":"https://openalex.org/I4210165985","display_name":"Harbor\u2013UCLA Medical Center","ror":"https://ror.org/05h4zj272","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1328359107","https://openalex.org/I4210165985"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ashraf S. Ibrahim","raw_affiliation_strings":["David Geffen School of Medicine at UCLA, Los Angeles, CA, United States","Division of Infectious Diseases, The Lundquist Institute for Biomedical Innovation at Harbor, University of California Los Angeles (UCLA) Medical Center, Torrance, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"David Geffen School of Medicine at UCLA, Los Angeles, CA, United States","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"Division of Infectious Diseases, The Lundquist Institute for Biomedical Innovation at Harbor, University of California Los Angeles (UCLA) Medical Center, Torrance, CA, United States","institution_ids":["https://openalex.org/I161318765","https://openalex.org/I177607063","https://openalex.org/I2801403999","https://openalex.org/I4210165985"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5039752717","display_name":"Priya Uppuluri","orcid":"https://orcid.org/0000-0002-5889-054X","observed_orcids":["https://orcid.org/0000-0002-5889-054X"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I177607063","display_name":"The Lundquist Institute","ror":"https://ror.org/025j2nd68","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I177607063"]},{"id":"https://openalex.org/I2801403999","display_name":"UCLA Medical Center","ror":"https://ror.org/04vq5kb54","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801403999"]},{"id":"https://openalex.org/I4210165985","display_name":"Harbor\u2013UCLA Medical Center","ror":"https://ror.org/05h4zj272","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1328359107","https://openalex.org/I4210165985"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Priya Uppuluri","raw_affiliation_strings":["David Geffen School of Medicine at UCLA, Los Angeles, CA, United States","Division of Infectious Diseases, The Lundquist Institute for Biomedical Innovation at Harbor, University of California Los Angeles (UCLA) Medical Center, Torrance, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"David Geffen School of Medicine at UCLA, Los Angeles, CA, United States","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"Division of Infectious Diseases, The Lundquist Institute for Biomedical Innovation at Harbor, University of California Los Angeles (UCLA) Medical Center, Torrance, CA, United States","institution_ids":["https://openalex.org/I161318765","https://openalex.org/I177607063","https://openalex.org/I2801403999","https://openalex.org/I4210165985"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5039752717"],"corresponding_institution_ids":["https://openalex.org/I161318765","https://openalex.org/I177607063","https://openalex.org/I2801403999","https://openalex.org/I4210165985"],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":2950,"currency":"USD","value_usd":2950},"fwci":3.0398,"has_fulltext":true,"cited_by_count":34,"citation_normalized_percentile":{"value":0.9328985,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":99},"biblio":{"volume":"13","issue":null,"first_page":"925821","last_page":"925821"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11037","display_name":"Fungal Infections and Studies","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10497","display_name":"Fungal and yeast genetics research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/candida-albicans","display_name":"Candida albicans","score":0.9710000157356262},{"id":"https://openalex.org/keywords/neonatal-candidiasis","display_name":"neonatal candidiasis","score":0.8849999904632568},{"id":"https://openalex.org/keywords/als3","display_name":"ALS3","score":0.8610000014305115},{"id":"https://openalex.org/keywords/passive-immunization","display_name":"passive immunization","score":0.8029999732971191},{"id":"https://openalex.org/keywords/transplacental-antibody-transfer","display_name":"transplacental antibody transfer","score":0.8880000114440918},{"id":"https://openalex.org/keywords/cell-wall-proteins","display_name":"cell wall proteins","score":0.621999979019165},{"id":"https://openalex.org/keywords/adjuvants","display_name":"adjuvants","score":0.6309999823570251},{"id":"https://openalex.org/keywords/complete-freund-s-adjuvant","display_name":"complete Freund's adjuvant","score":0.8169999718666077},{"id":"https://openalex.org/keywords/neutrophils","display_name":"neutrophils","score":0.9520000219345093},{"id":"https://openalex.org/keywords/preterm-infants","display_name":"preterm infants","score":0.7910000085830688},{"id":"https://openalex.org/keywords/systemic-candidiasis","display_name":"systemic candidiasis","score":0.7670000195503235}],"concepts":[{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.6540350914001465},{"id":"https://openalex.org/C2780917455","wikidata":"https://www.wikidata.org/wiki/Q310443","display_name":"Candida albicans","level":2,"score":0.6308814883232117},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6022511720657349},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5972775816917419},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.5667476654052734},{"id":"https://openalex.org/C145081991","wikidata":"https://www.wikidata.org/wiki/Q2576388","display_name":"Corpus albicans","level":3,"score":0.46283698081970215},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.4456779658794403},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4448786973953247},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.41811326146125793},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.32884150743484497},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.25337594747543335},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000831","descriptor_name":"Animals, Newborn","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002176","descriptor_name":"Candida albicans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D002177","descriptor_name":"Candidiasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005656","descriptor_name":"Fungal Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.3389/fimmu.2022.925821","doi":"https://doi.org/10.3389/fimmu.2022.925821","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2022.925821","pdf_url":null,"source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9355692","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9355692","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Immunol","raw_type":"Text"},{"id":"pmid:35935947","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35935947","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in immunology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:6bb22d61cbb445c8949cb2c380b5e24d","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/6bb22d61cbb445c8949cb2c380b5e24d","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, Vol 13 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fimmu.2022.925821","doi":"https://doi.org/10.3389/fimmu.2022.925821","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2022.925821","pdf_url":null,"source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1043745610","display_name":"Targeting the regulatory mechanism of hyphae to lateral yeast growth as a novel therapeutic approach against candidiasis","funder_award_id":"R01AI141794","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G3194132661","display_name":"Cross-Kingdom Vaccine Targeting Healthcare-Associated Priority Pathogens","funder_award_id":"R01AI141202","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G7285911849","display_name":"Development of Immunotherapeutic Strategies to Overcome Neonatal Candidiasis","funder_award_id":"R21HD097480","funder_id":"https://openalex.org/F4320337611","funder_display_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development"}],"funders":[{"id":"https://openalex.org/F4320309123","display_name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"},{"id":"https://openalex.org/F4320337611","display_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","ror":"https://ror.org/04byxyr05"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":53,"referenced_works":["https://openalex.org/W1517066215","https://openalex.org/W1854350893","https://openalex.org/W1970328266","https://openalex.org/W1973928480","https://openalex.org/W1973976214","https://openalex.org/W1987626041","https://openalex.org/W1990231839","https://openalex.org/W2005599815","https://openalex.org/W2010042214","https://openalex.org/W2017776891","https://openalex.org/W2018126167","https://openalex.org/W2018557829","https://openalex.org/W2031582295","https://openalex.org/W2032554581","https://openalex.org/W2037433854","https://openalex.org/W2049091194","https://openalex.org/W2049479913","https://openalex.org/W2066920574","https://openalex.org/W2074402196","https://openalex.org/W2076492225","https://openalex.org/W2076725846","https://openalex.org/W2082948091","https://openalex.org/W2095044244","https://openalex.org/W2098726188","https://openalex.org/W2098822237","https://openalex.org/W2099241550","https://openalex.org/W2103833466","https://openalex.org/W2106519526","https://openalex.org/W2108620409","https://openalex.org/W2119901233","https://openalex.org/W2140471823","https://openalex.org/W2155248348","https://openalex.org/W2163334818","https://openalex.org/W2171979845","https://openalex.org/W2239789730","https://openalex.org/W2400724561","https://openalex.org/W2513910741","https://openalex.org/W2799555303","https://openalex.org/W2799848852","https://openalex.org/W2800960099","https://openalex.org/W2801591369","https://openalex.org/W2935915453","https://openalex.org/W2950655724","https://openalex.org/W2952183412","https://openalex.org/W2965402820","https://openalex.org/W2968062885","https://openalex.org/W2969037002","https://openalex.org/W3007283104","https://openalex.org/W3026435944","https://openalex.org/W3153568677","https://openalex.org/W3180572190","https://openalex.org/W4234686938","https://openalex.org/W6637981096"],"related_works":["https://openalex.org/W4311744994","https://openalex.org/W2098726188","https://openalex.org/W2601864747","https://openalex.org/W2039575172","https://openalex.org/W7098729641","https://openalex.org/W2104991946","https://openalex.org/W2076492225","https://openalex.org/W2082331697","https://openalex.org/W2122999031","https://openalex.org/W2073624819"],"abstract_inverted_index":{"Pre-term":[0],"infants":[1,233],"in":[2,71,118,163,198,210,222,230],"neonatal":[3,36,224],"intensive":[4],"care":[5],"units":[6],"are":[7,38,111,207],"vulnerable":[8],"to":[9,104,213],"fungal":[10,21,161],"sepsis.":[11],"In":[12],"this":[13,188],"patient":[14],"population,":[15],"Candida":[16,228],"albicans":[17,52,202],"remains":[18],"the":[19,50,55,164,194,208,211,215],"predominant":[20],"pathogen":[22],"causing":[23],"high":[24],"morbidity":[25],"and":[26,61,121,169,219,239],"mortality,":[27],"despite":[28],"antifungal":[29],"therapy.":[30],"Thus,":[31],"new":[32],"preventative/therapeutic":[33],"strategies":[34,242],"against":[35],"candidiasis":[37,117],"needed.":[39],"Previously,":[40],"we":[41,97],"have":[42,247],"reported":[43],"that":[44,227],"vaccination":[45,241],"with":[46,79,87,126,139,152],"recombinant":[47],"forms":[48],"of":[49,54,101,115,144,156,166,172,181,196,217],"C.":[51,201],"N-termini":[53],"cell":[56],"wall":[57],"proteins":[58],"Als3":[59,120],"(rAls3p-N)":[60],"Hyr1":[62,122],"(rHyr1p-N)":[63],"protected":[64,81],"adult":[65],"mice":[66,167],"from":[67,83,200],"disseminated":[68,116],"candidiasis.":[69,225],"Further,":[70],"a":[72,92,99,135,140,235],"Phase":[73],"1b/2a":[74],"NDV-3A":[75],"(an":[76],"rAls3p-N":[77],"formulated":[78,151],"alum)":[80],"women":[82],"recurrent":[84],"vulvovaginal":[85],"candidiasis,":[86],"anti-Als3p":[88,107],"IgG2":[89],"isotype":[90],"being":[91],"biomarker":[93],"for":[94,113,187],"efficacy.":[95,189],"Here,":[96],"performed":[98],"proof":[100],"concept":[102],"study":[103],"evaluate":[105],"if":[106],"or":[108],"anti-Hyr1p":[109],"antibodies":[110,158,221],"important":[112,186],"prevention":[114],"neonates.":[119],"antigens":[123,245],"when":[124],"adjuvanted":[125],"complete":[127],"Freund\u2019s":[128,131],"adjuvant":[129,132],"(CFA)/incomplete":[130],"(IFA)":[133],"induced":[134],"robust":[136],"antibody":[137],"response":[138],"ten-fold":[141],"higher":[142],"titer":[143],"IgG2,":[145],"than":[146],"attained":[147],"by":[148],"either":[149],"antigen":[150],"alum.":[153],"Transplacental":[154],"transfer":[155,171],"these":[157,244],"significantly":[159],"reduced":[160],"burden":[162],"kidneys":[165],"pups,":[168],"adoptive":[170],"vaccinated":[173],"mothers\u2019":[174],"sera":[175],"into":[176],"pups":[177],"displayed":[178],"similar":[179],"levels":[180],"protection.":[182],"Neutrophils":[183],"were":[184],"found":[185],"Finally,":[190],"anti-Hyr1":[191,220],"antisera":[192],"potentiated":[193],"activity":[195],"fluconazole":[197],"protecting":[199],"infection.":[203],"Our":[204],"current":[205],"studies":[206],"first":[209],"field":[212],"emphasize":[214],"importance":[216],"anti-Als3":[218],"preventing":[223],"Considering":[226],"infections":[229],"low":[231],"birthweight":[232],"is":[234],"lethal":[236],"infection,":[237],"active":[238],"passive":[240],"using":[243],"could":[246],"profound":[248],"clinical":[249],"relevance.":[250]},"counts_by_year":[{"year":2026,"cited_by_count":9},{"year":2025,"cited_by_count":11},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":7}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-07-25T00:00:00"}